AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Knowing when to start retirement discussions with a financial advisor can enhance your planning. Get the guidance you need to succeed.
20,658 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Oklo is combining AI with nuclear reactor design to shorten development timelines and improve safety. This article br...
Early data from the 2026 World Cup in the U.S. shows host-city spending rising while visitor demand surges, challengi...
An unknown wallet moved $21.2 million of BONK tokens through a governance vote, draining the BonkDAO treasury and tri...
A practical, scenario-driven look at predicting where SpaceX headed by 2026 and how investors can approach this high-...
Apple is taking a guarded AI route, leaning on partnerships and modest capex. The strategy could alter AI investing d...
A bitcoin miner is branching into AI infrastructure, and the market has taken notice. The plan to turn U.S. sites int...
A Federal Reserve survey finds tariffs hit small firms' costs, forcing price hikes and hiring shifts as the burden sp...
The administration signals a possible tanker escort plan through the Strait of Hormuz, but says the Navy isn’t ready....
Billionaire investor Peter Thiel is pushing ultra-wealthy donors to disengage from The Giving Pledge, a move that cou...
A pivotal FDA decision sent Corcept Therapeutics stock soaring. This guide explains the news, what it could mean for ...
Iran is creating a transit oversight agency to vet and tax vessels passing through the Strait of Hormuz, a developmen...